How Caffeine Alters the Human Brain’s Electrical Braking System

Why It Matters

Because TMS‑based diagnostics are used to detect early neurodegenerative changes, caffeine‑induced modulation can mask abnormalities, leading to misdiagnosis. Controlling dietary stimulants therefore improves the reliability of clinical neurophysiology.

Key Takeaways

• Caffeine (200 mg) boosts short‑latency afferent inhibition in constant‑stimulus TMS.
• No significant effect observed with threshold‑tracking TMS protocol after caffeine.
• Caffeine lowers motor cortex excitability threshold, making neurons more responsive.
• Findings suggest caffeine can confound neurophysiological diagnostics if not controlled.
• Authors propose studying caffeine impact in Alzheimer’s and Parkinson’s patients.

Pulse Analysis

Transcranial magnetic stimulation (TMS) has become a cornerstone for probing cortical excitability and sensorimotor integration in both research and clinical settings. By delivering brief magnetic pulses, clinicians can assess how the brain’s motor cortex responds to sensory cues, a process that underlies many diagnostic protocols for conditions such as multiple sclerosis, stroke, and early‑stage neurodegeneration. Caffeine, a widely consumed adenosine antagonist, is known to increase acetylcholine and glutamate release, thereby heightening overall neural excitability—a factor that can subtly reshape TMS readouts.

The Rome‑based team led by Camilla Carrozzo demonstrated that a single 200 mg dose of caffeine amplifies short‑latency afferent inhibition when measured with a constant‑stimulus TMS approach. The enhancement was most pronounced at a 19‑21 ms interstimulus interval, suggesting that caffeine sharpens the brain’s rapid sensory‑motor braking mechanism. In contrast, the threshold‑tracking protocol, which uses lower‑intensity pulses, showed no statistically significant change, highlighting how methodological nuances can reveal or obscure pharmacological effects. Additionally, caffeine lowered the baseline magnetic threshold needed to evoke a muscle twitch, confirming its role in raising cortical responsiveness.

These findings carry practical weight for neurologists and neurophysiologists. Since routine caffeine consumption can artificially inflate inhibition metrics or lower excitability thresholds, patients should be advised to avoid coffee, energy drinks, or caffeine‑infused gum before undergoing TMS‑based assessments. Future research may extend this work to populations with Alzheimer’s or Parkinson’s disease, where cholinergic deficits already compromise sensorimotor inhibition. Understanding caffeine’s interaction with diseased neural circuits could refine diagnostic precision and perhaps even inform therapeutic strategies that leverage mild stimulants to modulate cortical function.